drugset / Trial / NCT00587275

Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI

NCT00587275

Phase 2 Terminated 4 enrolled Ocera Therapeutics
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this project is to test how safe and how well AST-120, an investigational product, works in treating too much acid in the stomach. Patients will be randomly assigned to one of two groups, AST-120 or a placebo for the first four weeks of the study. The patients will be switched to the other group (AST-120 or placebo)for the following four weeks.

Timeline

Start
2007-10
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Activated Charcoal Other / unclassified 2 g Oral